Core Scientific, Inc./tx (CORZZ) stock
CORZZNasdaqFinance ServicesFiscal year ends December 31Also trades as CORZ, CORZR, CORZW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 2/30223% above fair value
$12.85−1.46 (-10.20%)
Close on Oct 30, 2026Market cap $4.13BP/E –Yield –
Core Scientific total assets
Total assets on the balance sheet at the end of each period.
Core Scientific's total assets was $5.26B at Jun 30, 2026. For fiscal 2025 it was $2.35B, up 59.1% from the year before. The highest annual figure on record is $2.44B in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.35B | +59.1% |
| FY2024 | Dec 31, 2024 | $1.48B | +107.3% |
| FY2023 | Dec 31, 2023 | $712.16M | -11.8% |
| FY2022 | Dec 31, 2022 | $807.69M | -66.9% |
| FY2021 | Dec 31, 2021 | $2.44B | +16258993.3% |
| FY2020 | Dec 31, 2020 | $15.00K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $5.26B | +184.1% |
| Q1 FY2026 | Mar 31, 2026 | $3.07B | +104.9% |
| Q4 FY2025 | Dec 31, 2025 | $2.35B | +59.1% |
| Q3 FY2025 | Sep 30, 2025 | $2.17B | +163.3% |
| Q2 FY2025 | Jun 30, 2025 | $1.85B | +178.6% |
| Q1 FY2025 | Mar 31, 2025 | $1.50B | +84.0% |
| Q4 FY2024 | Dec 31, 2024 | $1.48B | +107.3% |
| Q3 FY2024 | Sep 30, 2024 | $824.59M | +16.9% |
| Q2 FY2024 | Jun 30, 2024 | $664.20M | -11.5% |
| Q1 FY2024 | Mar 31, 2024 | $813.97M | +7.1% |
| Q4 FY2023 | Dec 31, 2023 | $712.16M | -11.8% |
| Q3 FY2023 | Sep 30, 2023 | $705.46M | -49.8% |
| Q2 FY2023 | Jun 30, 2023 | $750.86M | -59.3% |
| Q1 FY2023 | Mar 31, 2023 | $760.02M | -71.9% |
| Q4 FY2022 | Dec 31, 2022 | $807.69M | -66.9% |
| Q3 FY2022 | Sep 30, 2022 | $1.40B | +304.5% |
| Q2 FY2022 | Jun 30, 2022 | $1.85B | +430.8% |
| Q1 FY2022 | Mar 31, 2022 | $2.70B | +677.6% |
| Q4 FY2021 | Dec 31, 2021 | $2.44B | +16258993.3% |
| Q3 FY2021 | Sep 30, 2021 | $347.07M | – |
| Q2 FY2021 | Jun 30, 2021 | $347.61M | – |
| Q1 FY2021 | Mar 31, 2021 | $347.74M | – |
| Q4 FY2020 | Dec 31, 2020 | $15.00K | – |